DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
First Batch Of DRDO And Dr Reddy's 2-DG COVID-19 Drug To Be Launched Early Next Week
Austria-Based Biotech Firm’s Drug Shows Promise To Fight Covid-19, Gets Approval For Phase II Clinical Trial
